首页 > 市场调查报告书 > 医疗设备

生技设备

缀合和标记服务、蛋白质和□标记、小分子和抗体缀合的全球市场：按分子类型分布、关键区域、行业趋势和预测（2023-2035）

市场调查报告书

商品编码

1319258

缀合和标记服务、蛋白质和□标记、小分子和抗体缀合的全球市场：按分子类型分布、关键区域、行业趋势和预测（2023-2035）

Conjugation & Labeling Services Market: Focus on Protein & Peptide Labeling, Small Molecule & Antibody Conjugation-Distribution by Type of Molecule, Key Geographical Regions: Industry Trends & Global Forecasts, 2023-2035

出版日期: 2023年04月04日 | 出版商:

Roots Analysis | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

在预测期内（2023-2035 年），全球结合和标籤服务市场规模预计将以高达 10% 的复合年增长率增长。

需要将缀合和标籤工作外包给服务提供商

目前，许多药物开发公司和研究机构缺乏生物偶联化学方面的技术专业知识，无法在内部处理先进的生物偶联技术，而这对于进行偶联过程至关重要。一些组织更愿意外包抗体偶联服务和蛋白质标记操作，以利用服务提供商的相关经验和专业知识。服务提供商往往拥有完善的方法以及各种生物分子化学修饰所需的各种试剂系统和缀合物。综合而言，这些因素导致越来越多的蛋白质标记、抗体标记和抗体偶联操作外包给 CRO，从而促进了市场增长。

结合和标记服务市场的现状

目前的市场情况遍布全球，有超过 170 家公司提供抗体偶联服务，超过 120 家公司提供蛋白质标记服务。总体而言，市场高度分散，大型企业拥有必要的专业知识，可以为不同类型的生物分子（包括蛋白质、抗体、□和小分子）提供生物偶联服务，有大、中、小型公司。值得注意的是，78% 的服务提供商提供抗体与半抗原的偶联。着名的例子（也在本报告中）包括 AAT Bioquest、Abzena、Fina Biosolutions、Life Tein、ProSci、Synaptic Systems 和 ViroGen。

细分分析 - 抗体偶联服务最受欢迎

用于研究目的的定制抗体偶联是该市场上最受欢迎的服务。各公司提供的抗体偶联服务包括HRP偶联、生物素偶联和荧光标记服务。抗体标记，也称为抗体缀合，涉及将标籤附加到抗体上。本报告涵盖与研究/诊断应用相关的所有抗体偶联服务。

片段分析 - 荧光标籤是生物分子标记的合适工具

荧光标籤广泛应用于蛋白质组学领域，用于检测蛋白质的位置和数量。它们还可以识别蛋白质复合物形成过程中的构象变化并跟踪生物过程。一些公司还用抗体或□标记荧光探针，并将其用于研究目的。

地区分析——北美占比最大

近年来，提供□□蛋白质标记、□标记、小分子偶联和抗体偶联服务的公司数量稳步增加。其中，大多数生物共轭服务提供商都位于北美。

分析趋势 - 服务提供商不断发展以满足市场需求

各个利益相关者正在共同努力与其他工业/非工业公司结成联盟。值得注意的是，自2018年以来，已形成70多个战略联盟。这表明服务提供商正在积极升级其缀合相关能力，以满足当前和预期的生物缀合物需求。该领域在不断发展，利益相关者正在积极参与与生物分子生物共轭和标记相关的活动（网络研讨会/会议/研讨会/会议/专题讨论会/峰会）。这些活动有可能为公司提供必要的平台，展示他们的想法和创新的生物共轭方法/技术，并与更广泛的受众讨论生物共轭的各种应用。考虑到定制生物分子的创新方法和对尖端技术的倾向，市场可能在 2023 年至 2035 年的预测期内快速发展。

本报告研究和分析了全球结合和标籤服务市场，提供有关当前市场状况、市场规模以及当前和未来机会的信息。

INTRODUCTION

Conjugation is the process of formation of a single, stable hybrid, wherein one of the entities is a molecule, such as protein, antibody, peptide and small molecule. These molecules can be conjugated with various modalities, such as haptens, enzymes, isotopes, fluorescent tags, carrier proteins, polymers, particle conjugates and photoreactive molecules. Bioconjugation is a subset of conjugation where one of the entity is a biomolecule, such as protein or an antibody. The synergistic combination of the conjugates and biomolecules confer desired functions, which otherwise are difficult to achieve with individual counterparts. These functionalities offer increased membrane permeability, target specificity, circulation time and enhanced pharmacokinetic properties. It is interesting to highlight that when the modification with conjugates lead to detection (direct / indirect) in bioimaging and immunoassays, bioconjugation is also referred to as biomolecule labeling. Presently, industry stakeholders employ various labeling approaches (fluorescent labeling and isotopic labeling) for protein profiling in order to quantify the compounds, and monitor and visualize the biological processes. Over the last couple of years, the pharmaceutical industry has also witnessed the utility of these complex entities across several application areas, such as development of conjugated drug therapeutics, drug delivery systems, disease diagnosis, invention of diagnostic tools, and high-throughput screening. Presently, a number of players across the globe are actively engaged in providing efficient antibody conjugation services for research purposes. Further, given the rising demand for conjugated biomolecules in the field of research and development, the conjugation and labeling services market is anticipated to witness substantial growth in the foreseen future.

SCOPE OF THE REPORT

The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report features:

An executive summary of the insights captured during our research. It offers a high-level view on the current state of conjugation and labeling services market and its likely evolution in the mid-long term.
A general overview of conjugation and labeling of biomolecules, highlighting the various advantages of biomolecule conjugation and labeling. It also provides details on the different types of biomolecular conjugates and labels. Further, the chapter concludes with a discussion on various applications of the conjugated and labeled biomolecules in the biotechnology and pharmaceutical industry.
A detailed assessment of the overall market landscape of the companies offering conjugation and labeling services, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of molecule(s) supported (proteins, peptides, small molecules, antibodies and other molecules), type of molecular conjugate(s) / label(s) (polymers, haptens, enzymes, fluorescent tags, FRET pairs, quantum dots, carrier proteins, streptavidin, chelators, bead coupling / particle conjugates, isotopes, photoreactives and other molecular conjugates / labels) and conjugation service(s) offered.
A company competitiveness analysis of conjugation and labeling service providers based on company strength (in terms of years of experience and company size) and service strength (in terms of type of molecule(s) supported, type of molecular conjugate(s) / label(s) and conjugation service(s) offered).
Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering conjugation and labeling services, located across North America, Europe and Asia-Pacific. Each profile features a brief overview of the company, recent developments and an informed future outlook.
A detailed analysis of the recent partnerships inked between stakeholders engaged in this domain, since 2018, covering acquisitions, service agreements, product development agreements, technology licensing agreements, and other relevant agreements.
An in-depth analysis of recent events (webinars / conferences / seminars / meetings / symposiums / summits) that were organized for stakeholders in the bioconjugation domain, based on several relevant parameters, such as year of event, event platform, type of event, geography, key focus areas, most active event organizers, active industry and non-industry players (in terms of number of speakers), seniority level of event speakers and geographical mapping of upcoming events.
A discussion on affiliated trends, key drivers and challenges, under a SWOT framework, featuring a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on the overall conjugation and labeling services market.

One of the key objectives of the report was to evaluate the current opportunity and future potential associated with conjugation and labeling services market, over the forecast period. We have provided informed estimates of the likely evolution of the market in the short to mid-term and long term, for the period 2023-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as type of molecule supported (proteins, peptides, small molecules, antibodies and other molecules), type of molecular conjugate / label (polymers, haptens, enzymes, fluorescent tags, bead coupling / particle conjugates, quantum dots, isotopes and other molecular conjugates / labels), and key geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the market growth.

The opinions and insights presented in the report were influenced by discussions held with stakeholders in this domain. The report features detailed transcripts of interviews held with the following industry stakeholders:

Sudhirdas Prayaga (President and Chief Executive Officer, Antibody Research)
Vishal Rai (Founder, Plabeltech)
Alastair Dent (Managing Director and Quality Director, Fleet Bioprocessing)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

KEY MARKET INSIGHTS

The Conjugation and Labeling Services Market: Focus on Protein Labeling, Peptide Labeling, Small Molecule Conjugation and Antibody Conjugation: Distribution by Type of Molecule Supported (Proteins, Peptides, Small Molecules, Antibodies and Other Molecules), Type of Molecular Conjugate / Label (Polymers, Haptens, Enzymes, Fluorescent Tags, Bead Coupling / Particle Conjugates, Quantum Dots, Isotopes and Other Molecular Conjugates / Labels), and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape, market size and the likely future potential of the conjugation and labeling services market, during the forecast period. Further, it highlights the efforts of several stakeholders engaged in this rapidly emerging domain of the pharmaceutical industry. Key inclusions of the report are briefly discussed below.

Need for Outsourcing Conjugation and Labeling Operations to Service Providers

A number of drug developers and research institutes currently lack the technical expertise related to bioconjugation chemistries, along with limited in-house capabilities and scarcity of advanced bioconjugation technologies, which are essential to carry out the process of conjugation. In order to leverage the relevant experience and expertise of service providers, several organizations prefer to outsource their antibody conjugation services and protein labeling operations. The service providers tend to be equipped with established methodologies, along with a wide range of reagent systems and conjugates required for the chemical modification of different biomolecules. These factors together will be responsible for market growth through increased outsourcing of protein labeling, antibody labeling and antibody conjugation services to the CROs.

Current Landscape of the Conjugation and Labeling Services Market

The current market landscape features the presence of over 170 companies providing antibody conjugation services and 120 companies providing service for protein labeling, spread across the globe. Overall, the market seems to be well-fragmented, featuring the presence of very large, large, mid-sized and small companies, which have the required expertise to offer bioconjugation services across different types of biomolecules, such as proteins, antibodies, peptides and small molecules. It is worth mentioning that 78% of the service providers offer antibody conjugation with haptens; notable examples (which have also been captured in this report) include AAT Bioquest, Abzena, Fina Biosolutions, Life Tein, ProSci, Synaptic Systems and ViroGen.

Segment Analysis - Antibody Conjugation Services are the most sought

Custom antibody conjugation for research purposes is the most sought service in this market. Some of the antibody conjugation services offered by the companies include conjugation with HRP conjugation, Biotin Conjugation and Fluorescent labeling services. Antibody labeling, which is also known as antibody conjugation, involves conjugating a tag to an antibody. In this report, we have captured all the antibody conjugation services that are relevant to research / diagnostic applications.

Segment Analysis - Fluorescent Tags are preferred tool for Biomolecule Labeling

Fluorescent tags are widely employed in the field of proteomics in order to detect the location of protein and quantity of the protein. These also lead to identification of conformational changes during protein complex formation and tracking the biological processes. Some of the companies also offer tagging of fluorescent probes with antibodies and peptides for research purposes.

Regional Analysis - North America to hold the Largest Share

Over the past few years, there has been a steady increase in the companies offering protein labeling, peptide labeling, small molecule conjugation and antibody conjugation services. Of these, majority of the bioconjugation service providers are based in North America.

Trend Analysis - Service Providers evolving to meet the market demand

Various stakeholders have been making consolidated efforts to forge alliance with other industry / non-industry players. It is worth highlighting that, since 2018, over 70 strategic partnerships have been inked, indicating that service providers are actively upgrading their conjugation related capabilities and accommodating the current and anticipated demand for bioconjugates. The field is continuously evolving; stakeholders are actively participating in events (webinars / conferences / seminars / meetings / symposiums / summits) related to bioconjugation and labeling of biomolecules. These events are likely to provide the necessary platform for companies to present their ideas, innovative bioconjugation methodologies / techniques and discuss various applications of bioconjugates to a wider audience. Given the inclination towards cutting-edge technologies, along with innovative approaches to tailor the biomolecules, we believe that the conjugation and labeling services market is likely to evolve at a rapid pace, during the forecast period 2023-2035.

RESEARCH METHODOLOGY

The data presented in this report has been gathered via secondary and primary research. For all our projects, we conduct interviews / surveys with experts in the area (academia, industry, medical practice and other associations) to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and technology segments. Wherever possible, the available data has been checked for accuracy from multiple sources of information.

The secondary sources of information include:

Annual reports
Investor presentations
SEC filings
Industry databases
News releases from company websites
Government policy documents
Industry analysts' views

While the focus has been on forecasting the market till 2035, the report also provides our independent views on various non-commercial trends emerging in the industry. This opinion is solely based on our knowledge, research and understanding of the relevant market gathered from various secondary and primary sources of information.

KEY QUESTIONS ANSWERED:

Question 1: What is the global market size of antibody conjugation services market?

Answer: The global antibody conjugation services market is anticipated to be worth USD 0.51.9 million by 2030.

Question 2: Which are the leading companies in the antibody conjugation services market?

Answer: Presently, more than 170 companies are engaged in offering antibody conjugation services, worldwide. The top players engaged in this domain (which have also been captured in this report) include Affinity Biologicals, BioLegend, Cell Signalling Technology, FAGUS Antibody Services, Novus Biologicals and ProteoGenix.

Question 3: How many companies offer peptide conjugation services?

Answer: More than 150 service providers possess the capabilities to offer peptide conjugation services.

Question 4: What percentage of service providers are engaged in offering conjugation and labeling services with both fluorescent tags and enzymes?

Answer: Close to 50% of the companies claim to offer conjugation and labeling of biomolecules using both fluorescent tags and enzymes; examples include Affigenix Biosolutions, Designer BioScience, Diatheva, GenPro Biotech and LAMPIRE.

Question 5: How many service providers offer services related to antibody-enzyme bioconjugation?

Answer: Nearly 45% of the service providers claim to have the requisite capabilities to aid in the bioconjugation of antibodies with various enzymes.

Question 7: What are the major factors driving the conjugation and labeling services market?

Answer: The factors driving the conjugation and labeling services market include the surge in demand for novel bioconjugate drugs, advanced drug delivery systems, and enhanced biomedical imaging and biomolecular detection.

Question 8: What are the leading market segments in the conjugation and labeling services market?

Answer: In terms of type of molecular conjugate / label, polymers currently account for the largest share (close to 25%) of the global conjugation and labeling services market. This can be attributed to several advantages offered by these conjugates to the biomolecules, including increased therapeutic potential, better stability, improved physicochemical properties and structural integrity. Further, in terms of type of molecule supported, proteins are likely to capture 45% of the current and future market.

Question 9: Which region captures the highest share in the conjugation and labeling services market?

Answer: Presently, the conjugation and labeling services market is dominated by North America, capturing around 45% of the overall market, followed by Europe (29%).

Question 10: What is the likely growth rate (CAGR) for conjugation and labeling services market?

Answer: The conjugation and labeling services market is projected to grow at a CAGR of ~10% during the forecast period 2023-2035.

CHAPTER OUTLINES

Chapter 1: is a preface providing an introduction to the full report, Conjugation and Labeling Services Market: Focus on Protein Labeling, Peptide Labeling, Small Molecule Conjugation and Antibody Conjugation, 2023-2035.
Chapter 2: provides an executive summary of the key insights captured in our research. It offers a high-level view on the current state of conjugation and labeling services market and its likely evolution in the mid-long term.
Chapter 3: provides a general overview of conjugation and labeling of biomolecules, highlighting the various advantages of biomolecule conjugation and labeling. It also provides details on the different types of biomolecular conjugates and labels. Additionally, it concludes with a discussion on various applications of the conjugated and labeled biomolecules in the biotechnology and pharmaceutical industry.
Chapter 4: includes detailed assessment of the overall market landscape of the companies offering conjugation and labeling services, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of molecule(s) supported (proteins, peptides, small molecules, antibodies and other molecules), type of molecular conjugate(s) / label(s) (polymers, haptens, enzymes, fluorescent tags, FRET pairs, quantum dots, carrier proteins, streptavidin, chelators, bead coupling / particle conjugates, isotopes, photoreactives and other molecular conjugates / labels) and conjugation service(s) offered.
Chapter 5: presents a detailed company competitiveness analysis of conjugation and labeling service providers based on company strength (in terms of years of experience and company size) and service strength (in terms of type of molecule(s) supported, type of molecular conjugate(s) / label(s) and conjugation service(s) offered).
Chapter 6: features detailed profiles of prominent players (shortlisted based on a proprietary criterion) offering conjugation and labeling services, located across North America, Europe and Asia-Pacific. Each profile features a brief overview of the company, recent developments and an informed future outlook.
Chapter 7: features a detailed analysis of the various partnerships inked between stakeholders engaged in this domain, since 2018, covering acquisitions, service agreements, product development agreements, technology licensing agreements, and other relevant agreements.
Chapter 8: features a detailed analysis of recent events (webinars / conferences / seminars / meetings / symposiums / summits) that were organized for stakeholders in the bioconjugation domain, based on several relevant parameters, such as year of event, event platform, type of event, geography, key focus areas, most active event organizers, active industry and non-industry players (in terms of number of speakers), seniority level of event speakers and geographical mapping of upcoming events.
Chapter 9: provides information on the affiliated trends, key drivers and challenges, under a reliable SWOT framework. The chapter includes a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on the overall conjugation and labeling services market.
Chapter 10: presents a comprehensive market forecast and opportunity analysis, highlighting the future potential of the market till the year 2035. We have segregated the current and upcoming opportunity based on type of molecule supported (proteins, peptides, small molecules, antibodies and other molecules), type of molecular conjugate / label (polymers, haptens, enzymes, fluorescent tags, bead coupling / particle conjugates, quantum dots, isotopes and other molecular conjugates / labels), and key geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America).
Chapter 11: summarizes the overall report. In this chapter, we have provided a list of key takeaways from the report, and expressed our independent opinion related to the research and analysis described in the previous chapters.
Chapter 12: presents the transcripts of interviews conducted with key stakeholders in this industry. The chapter provides details of our conversations with Sudhirdas Prayaga (President and Chief Executive Officer, Antibody Research), Vishal Rai (Founder, Plabeltech), and Alastair Dent (Managing Director and Quality Director, Fleet Bioprocessing).
Chapter 13: is an appendix, which contains tabulated data and numbers for all the figures included in the report.
Chapter 14: is an appendix, which contains a list of companies and organizations mentioned in this report.

1. PREFACE

1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Chapter Overview
3.2. Overview of Biomolecule Conjugation and Labeling
3.3. Types of Biomolecular Conjugates and Labels
3.4. Applications of Conjugated and Labeled Biomolecules
3.5. Concluding Remarks

4. CONJUGATION AND LABELING SERVICE PROVIDERS: MARKET LANDSCAPE

4.1. Chapter Overview
4.2. Conjugation and Labeling Service Providers: Overall Market Landscape
- 4.2.1. Analysis by Year of Establishment
- 4.2.2. Analysis by Company Size
- 4.2.3. Analysis by Location of Headquarters
- 4.2.4. Analysis by Company Size and Location of Headquarters
- 4.2.5. Analysis by Type of Molecule(s) Conjugated / Labeled
- 4.2.6. Analysis by Type of Molecular Conjugate(s) / Label(s) Used
  - 4.2.6.1. Analysis by Type of Enzyme(s) Used
  - 4.2.6.2. Analysis by Type of Hapten(s) Used
- 4.2.7. Analysis by Conjugation Service(s) Offered

5. COMPANY COMPETITIVENESS ANALYSIS

5.1. Chapter Overview
5.2. Assumptions / Key Parameters
5.3. Methodology
5.4. Company Competitiveness Analysis
- 5.4.1. Conjugation and Labeling Service Providers based in North America
- 5.4.2. Conjugation and Labeling Service Providers based in Europe
- 5.4.3. Conjugation and Labeling Service Providers based in Asia-Pacific

6. COMPANY PROFILES

6.1. Chapter Overview
6.2. AltaBioscience
- 6.2.1. Company Overview
- 6.2.2. Recent Developments and Future Outlook
6.3. Bachem
- 6.3.1. Company Overview
- 6.3.2. Recent Developments and Future Outlook
6.4. Bio-Synthesis
- 6.4.1. Company Overview
- 6.4.2. Recent Developments and Future Outlook
6.5. Cayman Chemical
- 6.5.1. Company Overview
- 6.5.2. Recent Developments and Future Outlook
6.6. CliniSciences
- 6.6.1. Company Overview
- 6.6.2. Recent Developments and Future Outlook
6.7. Eurogentec
- 6.7.1. Company Overview
- 6.7.2. Recent Developments and Future Outlook
6.8. GBI (formerly known as Goodwin Biotechnology)
- 6.8.1. Company Overview
- 6.8.2. Recent Developments and Future Outlook
6.9. Mimotopes
- 6.9.1. Company Overview
- 6.9.2. Recent Developments and Future Outlook
6.10. Peptide Institute
- 6.10.1. Company Overview
- 6.10.2. Recent Developments and Future Outlook
6.11. piCHEM
- 6.11.1. Company Overview
- 6.11.2. Recent Developments and Future Outlook

7. PARTNERSHIPS AND COLLABORATIONS

7.1. Chapter Overview
7.2. Partnership Models
7.3. Conjugation and Labeling Services: Partnerships and Collaborations
- 7.3.1. Analysis by Year of Partnership
- 7.3.2. Analysis by Type of Partnership
- 7.3.3. Analysis by Year and Type of Partnership
- 7.3.4. Analysis by Type of Partner
- 7.3.5. Analysis by Year of Partnership and Type of Partner
- 7.3.6. Analysis by Type of Partnership and Type of Partner
- 7.3.7. Analysis by Location of Headquarters of Partner
- 7.3.8. Analysis by Type of Partnership and Location of Headquarters of Partner
- 7.3.9. Most Active Players: Analysis by Number of Partnerships
- 7.3.10. Analysis by Geography
  - 7.3.10.1. Intercontinental and Intracontinental Deals
  - 7.3.10.2. Local and International Deals

8. GLOBAL EVENT ANALYSIS

8.1. Chapter Overview
8.2. Scope and Methodology
8.3. Conjugation and Labeling Services: Global Event Analysis
- 8.3.1. Analysis by Year of Event
- 8.3.2. Analysis by Event Platform
- 8.3.3. Analysis by Type of Event
- 8.3.4. Analysis by Year and Type of Event
- 8.3.5. Analysis by Geography
- 8.3.6. Word Cloud Analysis: Evolutionary Trends in Event Agenda / Key Focus Area
- 8.3.7. Most Active Organizers: Analysis by Number of Events
8.4. Global Events: Speaker Analysis
- 8.4.1. Most Active Industry Players: Analysis by Number of Speakers
- 8.4.2. Most Active Non-Industry Players: Analysis by Number of Speakers
- 8.4.3. Analysis by Seniority Level of Event Speakers
8.5. Geographical Mapping of Upcoming Events
8.6. Concluding Remarks

9. SWOT ANALYSIS

9.1. Chapter Overview
9.2. Conjugation and Labeling Services: SWOT Analysis
- 9.2.1. Comparison of SWOT Factors

10. MARKET FORECAST AND OPPORTUNITY ANALYSIS

10.1. Chapter Overview
10.2. Key Assumptions and Forecast Methodology
10.3. Global Conjugation and Labeling Services Market, 2023-2035
10.4. Conjugation and Labeling Services Market: Analysis by Type of Molecule
- 10.4.1. Conjugation and Labeling Services Market for Proteins, 2023-2035
- 10.4.2. Conjugation and Labeling Services Market for Antibodies, 2023-2035
- 10.4.3. Conjugation and Labeling Services Market for Peptides, 2023-2035
- 10.4.4. Conjugation and Labeling Services Market for Small Molecules, 2023-2035
- 10.4.5. Conjugation and Labeling Services Market for Other Molecules, 2023-2035
10.5. Conjugation and Labeling Services Market: Analysis by Type of Molecular Conjugate / Label
- 10.5.1. Conjugation and Labeling Services Market for Polymers, 2023-2035
- 10.5.2. Conjugation and Labeling Services Market for Haptens, 2023-2035
- 10.5.3. Conjugation and Labeling Services Market for Enzymes, 2023-2035
- 10.5.4. Conjugation and Labeling Services Market for Fluorescent Tags, 2023-2035
- 10.5.5. Conjugation and Labeling Services Market for Bead Coupling / Particle Conjugates, 2023-2035
- 10.5.6. Conjugation and Labeling Services Market for Quantum Dots, 2023-2035
- 10.5.7. Conjugation and Labeling Services Market for Isotopes, 2023-2035
- 10.5.8. Conjugation and Labeling Services Market for Other Molecular Conjugates / Labels, 2023-2035
10.6. Conjugation and Labeling Services Market: Analysis by Key Geographical Regions
- 10.6.1. Conjugation and Labeling Services Market in North America, 2023-2035
- 10.6.2. Conjugation and Labeling Services Market in Europe, 2023-2035
- 10.6.3. Conjugation and Labeling Services Market in Asia-Pacific, 2023-2035
- 10.6.4. Conjugation and Labeling Services Market in Middle East and North Africa, 2023-2035
- 10.6.5. Conjugation and Labeling Services Market in Latin America, 2023-2035

11. CONCLUSION

12. EXECUTIVE INSIGHTS

13. APPENDIX 1: TABULATED DATA

14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

简介目录图表

LIST OF TABLES

Table 4.1 Conjugation and Labeling Service Providers: List of Companies
Table 4.2 Conjugation and Labeling Service Providers: Information on Type of Molecule(s) Conjugated / Labeled
Table 4.3 Conjugation and Labeling Service Providers: Information on Type of Molecular Conjugate(s) / Label(s) Used
Table 4.4 Conjugation and Labeling Service Providers: Information on Type of Enzyme(s) Used
Table 4.5 Conjugation and Labeling Service Providers: Information on Type of Hapten(s) Used
Table 4.6 Conjugation and Labeling Service Providers: Information on Conjugation Service(s) Offered
Table 6.1 Conjugation and Labeling Service Providers: List of Companies Profiled
Table 6.2 AltaBioscience: Company Overview
Table 6.3 AltaBioscience: Recent Developments and Future Outlook
Table 6.4 Bachem: Company Overview
Table 6.5 Bachem: Recent Developments and Future Outlook
Table 6.6 Bio-Synthesis: Company Overview
Table 6.7 Cayman Chemical: Company Overview
Table 6.8 Cayman Chemical: Recent Developments and Future Outlook
Table 6.9 CliniSciences: Company Overview
Table 6.10 CliniSciences: Recent Developments and Future Outlook
Table 6.11 Eurogentec: Company Overview
Table 6.12 Eurogentec: Recent Developments and Future Outlook
Table 6.13 GBI: Company Overview
Table 6.14 GBI: Recent Developments and Future Outlook
Table 6.15 Mimotopes: Company Overview
Table 6.16 Mimotopes: Recent Developments and Future Outlook
Table 6.17 Peptide Institute: Company Overview
Table 6.18 Peptide Institute: Recent Developments and Future Outlook
Table 6.19 piCHEM: Company Overview
Table 7.1 Partnerships and Collaborations: Information on Year of Agreement, Type of Partnership and Type of Partner, 2018-2022
Table 7.2 Partnerships and Collaborations: Information on Type of Agreement (Country-wise and Continent-wise), 2018-2022
Table 8.1 List of Global Events related to Conjugation and Labeling of Biomolecules
Table 13.1 Conjugation and Labeling Service Providers: Distribution by Year of Establishment
Table 13.2 Conjugation and Labeling Service Providers: Distribution by Company Size
Table 13.3 Conjugation and Labeling Service Providers: Distribution by Location of Headquarters
Table 13.4 Conjugation and Labeling Service Providers: Distribution by Company Size and Location of Headquarters
Table 13.5 Conjugation and Labeling Service Providers: Distribution by Type of Molecule(s) Conjugated / Labeled
Table 13.6 Conjugation and Labeling Service Providers: Distribution by Type of Molecular

Conjugate(s) / Label(s) Used

Table 13.7 Conjugation and Labeling Service Providers: Distribution by Type of Enzyme(s) Used
Table 13.8 Conjugation and Labeling Service Providers: Distribution by Type of Hapten(s) Used
Table 13.9 Conjugation and Labeling Service Providers: Distribution by Conjugation Service(s) Offered
Table 13.10 Partnerships and Collaborations: Cumulative Year-wise Trend, 2018-2022
Table 13.11 Partnerships and Collaborations: Distribution by Type of Partnership
Table 13.12 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 13.13 Partnerships and Collaborations: Distribution by Type of Partner
Table 13.14 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Table 13.15 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Table 13.16 Partnerships and Collaborations: Distribution by Location of Headquarters of Partner
Table 13.17 Partnerships and Collaborations: Distribution by Type of Partnership and Location of Headquarters of Partner
Table 13.18 Most Active Players: Distribution by Number of Partnerships
Table 13.19 Partnerships and Collaborations: Distribution by Region
Table 13.20 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 13.21 Partnerships and Collaborations: Local and International Agreements
Table 13.22 Global Event Analysis: Cumulative Year-wise Trend, 2018-2022
Table 13.23 Global Event Analysis: Distribution by Event Platform
Table 13.24 Global Event Analysis: Distribution by Type of Event
Table 13.25 Global Event Analysis: Distribution by Year and Type of Event
Table 13.26 Global Event Analysis: Distribution by Location of Event
Table 13.27 Most Active Organizers: Distribution by Number of Events
Table 13.28 Most Active Industry Players: Distribution by Number of Speakers
Table 13.29 Most Active Non-Industry Players: Distribution by Number of Speakers
Table 13.30 Seniority Level of Event Speakers: Distribution by Number of Speakers
Table 13.31 Global Conjugation and Labeling Services Market, 2023-2035 (USD Million)
Table 13.32 Conjugation and Labeling Services Market: Distribution by Type of Molecule, 2023 and 2035
Table 13.33 Conjugation and Labeling Services Market for Proteins, 2023-2035 (USD Million)
Table 13.34 Conjugation and Labeling Services Market for Antibodies, 2023-2035 (USD Million)
Table 13.35 Conjugation and Labeling Services Market for Peptides, 2023-2035 (USD Million)
Table 13.36 Conjugation and Labeling Services Market for Small Molecules, 2023-2035 (USD Million)
Table 13.37 Conjugation and Labeling Services Market for Other Molecules, 2023-2035 (USD Million)
Table 13.38 Conjugation and Labeling Services Market: Distribution by Type of Molecular Conjugate / Label, 2023 and 2035
Table 13.39 Conjugation and Labeling Services Market for Polymers, 2023-2035 (USD Million)
Table 13.40 Conjugation and Labeling Services Market for Haptens, 2023-2035 (USD Million)
Table 13.41 Conjugation and Labeling Services Market for Enzymes, 2023-2035 (USD Million)
Table 13.42 Conjugation and Labeling Services Market for Fluorescent Tags, 2023-2035 (USD Million)
Table 13.43 Conjugation and Labeling Services Market for Bead Coupling / Particle Conjugates, 2023-2035 (USD Million)
Table 13.44 Conjugation and Labeling Services Market for Quantum Dots, 2023-2035 (USD Million)
Table 13.45 Conjugation and Labeling Services Market for Isotopes, 2023-2035 (USD Million)
Table 13.46 Conjugation and Labeling Services Market for Other Molecular Conjugates / Labels, 2023-2035 (USD Million)
Table 13.47 Conjugation and Labeling Services Market: Distribution by Key Geographical Regions, 2023 and 2035
Table 13.48 Conjugation and Labeling Services Market in North America, 2023-2035 (USD Million)
Table 13.49 Conjugation and Labeling Services Market in Europe, 2023-2035 (USD Million)
Table 13.50 Conjugation and Labeling Services Market in Asia-Pacific, 2023-2035 (USD Million)
Table 13.51 Conjugation and Labeling Services Market in Middle East and North Africa, 2023-2035 (USD Million)
Table 13.52 Conjugation and Labeling Services Market in Latin America, 2023-2035 (USD Million)

LIST OF FIGURES

Figure 2.1 Executive Summary: Overall Market Landscape
Figure 2.2 Executive Summary: Partnerships and Collaborations
Figure 2.3 Executive Summary: Global Event Analysis
Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Advantages of Biomolecule Conjugation and Labeling
Figure 3.2 Types of Biomolecular Conjugates and Labels
Figure 4.1 Conjugation and Labeling Service Providers: Distribution by Year of Establishment
Figure 4.2 Conjugation and Labeling Service Providers: Distribution by Company Size
Figure 4.3 Conjugation and Labeling Service Providers: Distribution by Location of Headquarters
Figure 4.4 Conjugation and Labeling Service Providers: Distribution by Company Size and Location of Headquarters
Figure 4.5 Conjugation and Labeling Service Providers: Distribution by Type of Molecule(s) Conjugated / Labeled
Figure 4.6 Conjugation and Labeling Service Providers: Distribution by Type of Molecular